Working... Menu
Trial record 15 of 356 for:    hepatic steatosis AND fat AND Nonalcoholic Fatty Liver

Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03281083
Recruitment Status : Terminated (Difficult recruitment and end of funding.)
First Posted : September 13, 2017
Last Update Posted : September 14, 2017
Singapore Clinical Research Institute
Singapore Institute for Clinical Sciences
Singapore Bioimaging Consortium
Tan Tock Seng Hospital
Singapore General Hospital
Ng Teng Fong General Hospital
Changi General Hospital
Khoo Teck Puat Hospital
National University Health System, Singapore
Information provided by (Responsible Party):
Paul M. Yen, Duke-NUS Graduate Medical School

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 28, 2016
  Actual Study Completion Date : July 28, 2016

Publications automatically indexed to this study by Identifier (NCT Number):